Home › Funds › Deep Track Capital, LP › CLDX

Deep Track Capital, LP position in CLDX

CELLDEX THERAPEUTICS INC NEW · Health Care

Deep Track Capital, LP reported holding 2,125,532 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q3 2026 13F filing — a position valued at US$68.9M, representing 1.15% of its reported portfolio and ranking #30 among its reported holdings. Deep Track Capital, LP has disclosed CLDX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)2.13M sh
Reported value held$68.89M
Portfolio Weight1.15%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's CLDX position evolved

Deep Track Capital, LP first disclosed a stake in CLDX in Q4 2024 at 1,540,132 shares (US$38.9M). The position peaked in Q2 2026 at 2,939,151 shares, worth US$109.4M. Across 8 filings, Deep Track Capital, LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,125,532 shares valued at US$68.9M — a reduction of -813,619 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2025 (shares rose 12% over the following quarter), a 32% trim in Q1 2026 (shares rose 17% over the following quarter), a 129% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.54M $38.92M New
Q1 2025 2.00M $36.30M Add
Q2 2025 2.00M $40.70M Hold
Q3 2025 2.00M $51.74M Hold
Q4 2025 1.90M $51.62M Reduce
Q1 2026 1.28M $40.73M Reduce
Q2 2026 2.94M $109.37M Add
Q3 2026 2.13M $68.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDX and 13F data

CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 39 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$164.2M), EVENTIDE ASSET MANAGEMENT, LLC (US$61.5M), Commodore Capital LP (US$50.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDX

All CLDX fund holders →

FAQ

How long has Deep Track Capital, LP held CLDX?

Deep Track Capital, LP has disclosed CLDX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Deep Track Capital, LP's current position in CLDX?

As of Q3 2026, Deep Track Capital, LP holds 2.13M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $68.89M, representing 1.15% of its reported portfolio and ranking #30.

Has Deep Track Capital, LP been buying or selling CLDX?

In the latest 13F filing (Q3 2026), Deep Track Capital, LP reduced its position in CLDX. The position peaked in Q2 2026 at 2.94M shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, EVENTIDE ASSET MANAGEMENT, LLC, Commodore Capital LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.